What Should Parents Know About COVID-19 Vaccines?
With children back in school and COVID-19 cases persisting, parents may be concerned and seek information about the vaccine. What should they know about the COVID-19 vaccine for children?
COVID19 Vaccine
NASEM: Building Parents’ Confidence in COVID-19 Vaccines
Having the tough conversations. NASEM offers recommendations for communicating with parents of young children about COVID-19 vaccines.
FDA Expert Panel to Weigh Approval of Moderna, Johnson & Johnson Booster Shots
Panel will consider whether third Moderna shot should contain half the original dose, best timing for second shot of single-dose J&J vaccine.
FDA Panel Supports Moderna Booster Shot for Older Adults, People at High Risk
An expert advisory panel to the U.S. Food and Drug Administration on Thursday recommended a half-dose booster shot of the Moderna vaccine be given to certain recipients six months after their second shot.
World Health Organization Releases Updated Guidelines on Treatment Strategies for COVID-19
In this fifth update to the living guidelines on drugs for the treatment of COVID-19, the World Health Organization analyzed results of clinical trials that assessed the effects of casirivimab-imdevimab and corticosteroids in patients with severe and non-severe disease.
Protection Against SARS-CoV-2 Wanes Months After BNT162b2 Vaccination
Declines seen in humoral responses, effectiveness against SARS-CoV-2 infection, within several months after the second dose.
FDA Questions Strength of Johnson and Johnson Booster Shot Data
Agency says key test used by the company to measure immune response from booster shot six months after the original shot likely not sensitive enough.
T-Cell and Humoral Response to SARS-CoV-2 Vaccine in Patients With MS on Ocrelizumab
Researchers sought to determine the T-cell and antibody response to the SARS-CoV-2 vaccine in patients with multiple sclerosis treated with ocrelizumab, compared with healthy individuals.
Immunity, T-Cell Responses in Patients Vaccinated Against SARS-CoV-2 With Low-Dose mRNA-1273
Investigators conducted a study to assess immune responses among individuals vaccinated against SARS-CoV-2 infection with low-dose mRNA-1273.
Johnson & Johnson Seeks FDA Emergency Approval for Its Booster Shot
FDA advisory panel will review J&J data next week and vote on whether to recommend boosters
- Loading...
Loading...
Next post in COVID19
Loading... 
Loading...